SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Research and Markets: Lung Cancer Global Clinical Trials Review, H2, 2012 Out Now
[January 09, 2013]

Research and Markets: Lung Cancer Global Clinical Trials Review, H2, 2012 Out Now

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/rg49b3/lung_cancer) has announced the addition of GlobalData's new report "Lung Cancer Global Clinical Trials Review, H2, 2012" to their offering.

The clinical trial report, Lung Cancer Global Clinical Trials Review, H2, 2012" provides data on the Lung Cancer clinical trial scenario. this report provides elemental information and data relating to the clinical trials on Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research nd in-house analysis by a team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations


- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Companies Mentioned:

Eli Lilly and Company

Pfizer Inc.

AstraZeneca PLC

Bristol-Myers Squibb Company

Hoffmann-La Roche Inc.

GlaxoSmithKline plc

Amgen Inc.

Sanofi

Merck & Co., Inc.

Genentech, Inc.

Novartis AG

F. Hoffmann-La Roche Ltd.

Bayer AG

Boehringer Ingelheim GmbH

Merck KGaA

Clinical Trial Overview of Merck KGaA

Abbott Laboratories

Daiichi Sankyo Company, Limited

Celgene Corporation

Zhejiang Beta Pharma Inc.

ImClone LLC

Memorial Sloan Kettering Cancer Center

Mayo Clinic

Barbara Ann Karmanos Cancer Institute

Stanford University

Massachusetts General Hospital

Vanderbilt-Ingram Cancer Center

Fox Chase Cancer Center

Samsung (News - Alert) Medical Center

Sidney Kimmel Comprehensive Cancer Center

Case Comprehensive Cancer Center

Kyoto University

Clinical Trial Overview of Kyoto University

For more information visit http://www.researchandmarkets.com/research/rg49b3/lung_cancer

Source (News - Alert): GlobalData


[ Back To TMCnet.com's Homepage ]





LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.